Accuray has introduced a new all-in-one adaptive radiotherapy solution, Accuray Stellar, tailored initially for the US market.
This new technology provides a comprehensive suite of tools designed to support clinical teams in meeting the treatment needs of patients undergoing radiotherapy.
The company said that Accuray Stellar is a configuration of the Radixact Treatment Delivery System.
Related: Navigation Sciences receives $400,000 STTR grant for its NaviSci System
Designed to transform cancer care, the solution integrates with the company’s current software and hardware solutions, as well as technologies from vendor partners.
This integration broadens the spectrum of radiation delivery alternatives and simplifies the treatment process for every individual.
Clinicians using the Accuray Stellar technology will have access to a solution capable of delivering a full range of modalities, including surface-guided radiation therapy (SGRT), image-guided radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT).
The company noted that this technology is intended to improve treatment outcomes for standard radiation therapy indications, including various cancers, as well as support treatments such as total marrow irradiation.
The Stellar solution is designed to deliver radiation with precision, adjusting for changes in tumour size or shape, and movement of tumour or patient during treatment.
It provides a pathway to adaptive radiotherapy, which includes real-time motion tracking and correction with Synchrony technology, offline adaptive protocols with PreciseART, and an online-adaptive-ready interface, essential for evolving patient care.
The foundation of Accuray’s adaptive radiotherapy technology is ClearRT helical kVCT imaging, which is engineered to capture “high-resolution” images swiftly, offering healthcare professionals tumour clarity and anatomy visibility.
Accuray CEO and president Suzanne Winter said: “Innovations in radiation medicine, such as adaptive radiotherapy, are enabling clinicians to deliver more precise treatments that can lead to better tumour control and potentially higher survival rates.
“Our goal with Accuray Stellar is to provide tools that make it simple, fast and practical for medical teams to adopt adaptive radiotherapy techniques where needed, regardless of the stage of the patient’s cancer journey. The solution reflects our commitment to innovating with purpose and compassion, and to redefining what’s possible in personalised, radiotherapy treatments.”
Last year, Accuray secured CE Mark approval for its computed tomography (CT)-guided helical radiotherapy system, Accuray Helix.
